Molecular genetic characteristics of colorectal cancer
https://doi.org/10.18027/2224-5057-2023-13-4-78-83
Abstract
Colorectal cancer ranks third among all cancers. More than 1 million cases are registered annually in the world, half of which are fatal. The investigation of the molecular genetic mechanisms of tumors’ development is relevant, which is an important contribution to the prospect of determining the prognosis and treatment tactics. This review presents the current classification of the mechanisms of tumor progression in colorectal cancer.
About the Authors
B. D. Seferov
The Institute “Medical Academy named after S. I. Georgievsky”, V. I. Vernadsky Crimean Federal University;
“Center of Clinical Oncology and Hematology”
Russian Federation
Russian Federation
Bekir D. Seferov, MD, PhD, Assistant of the Department of Oncology;
Director
Simferopol
O. Yu. Grickevich
The Institute “Medical Academy named after S. I. Georgievsky”, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Olga Yu. Grickevich, Junior Researcher, Central Research Laboratory
Simferopol
A. E. Lazarev
The Institute “Medical Academy named after S. I. Georgievsky”, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Artyom E. Lazarev, Junior Researcher, Central Research Laboratory
Simferopol
E. P. Golubinskaya
The Institute “Medical Academy named after S. I. Georgievsky”, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Elena P. Golubinskaya, MD, PhD, DSc, Leading Researcher, Central Research Laboratory
Simferopol
P. E. Maksimova
The Institute “Medical Academy named after S. I. Georgievsky”, V. I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Рolina E. Maksimova, Student of the First Medical Faculty
Simferopol
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 ; 71 (3) : 209–249. doi:10.3322/caac.21660.
2. Кит О.И., Дженкова Е.А., Мирзоян Э.А., Геворкян Ю.А., Сагакянц А.Б., Тимошкина Н.Н., идр. Молекулярногенетическая классификация подтипов колоректального рака : современное состояние проблемы. Южно-Российский онкологический журнал / SouthRussianJournalofCancer. 2021 ; 2 (2) : 50–56.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 ; 61 (5) : 759–767. doi:10.1016/0092-8674(90)90186-i.
4. Valenta T., Hausmann G., Basler K. The many faces and functions of b-catenin. EMBO J. 2012 ; 31 : 2714–2736.
5. Morin PJ. beta-catenin signaling and cancer. Bioessays. 1999 ; 21 (12) : 1021–1030.
6. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 2003 ; 63 (12) : 3145–3153.
7. Shivanna S., Harrold I., Shashar M., Meyer R., Kiang C., Francis J., et al. The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway. J Biol Chem. 2015. Doi: 10.1074/jbc. M114.616623.
8. Muller MF, Ibrahim AEK, Arends MJ. Molecular pathological classifi cation of colorectal cancer. VirchowsArch. 2016 ; 469 (2) : 125–134.
9. Bosman F, Yan P. Molecular pathology of colorectal cancer. Pol J Pathol. 2014 ; 65 (4) : 257–266.
10. Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010 ; 138 (6) : 2059–72.
11. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15 / BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998 ; 20 : 189–93.
12. Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in Cancer : molecular mechanisms and opportunities for Cancer therapy. Mol Cancer. 2021 ; 20 (1) : 15. doi: 10.1186/s12943-020-01305-3.
13. Jacobsen A, Bosch LJW, Martens-de Kemp SR, Carvalho B, Sillars-Hardebol AH, Dobson RJ, et al. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. SciRep. 2018 ; 14 ; 8 (1) : 7522.
14. Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010 ; 138 (6) : 2059–72.
15. Santini D, Loupakis F, Vincenzi B, Floriani I, Stasi I, Canestrari, E, et al. High concordance of KRAS status between primary colorectal tumors and related metastatic sites : implications for clinical practice. Oncologist. 2008 ; 13 (12) : 1270–1275.
16. ТороповскийА. Н., ПавловаО. Н., ВикторовД. А., Никитин А.Г. Молекулярно-генетические механизмы сигнального каскада RAS-RAF-MEK-ERK, связанные с развитием опухолевого процесса и назначением таргетных препаратов при колоректальном раке. Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье. 2021 ; (4) : 25–35.
17. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004 ; 116 (6) : 855–867. doi:10.1016/s0092-8674(04)00215-6.
18. Samuels Y, Velculescu VE. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle. 2004 ; 3 (10) : 1221–4.
19. Телышева Е.Н., Новикова Е.И., Снигирева Г.П. Молекулярно-генетические маркеры при колоректальном раке. Вестник Российского научного центра рентгенорадиологии Минздрава России. 2019 ; 19 : 3 : 96–121.
20. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993 ; 260 (5109) : 816–9.
21. Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev ClinOncol. 2010 ; 7 (3) : 153–62.
22. Федянин М.Ю., Трякин А.А., Тюляндин С.А. Роль микросателлитной нестабильности при раке толстой кишки. Тазоваяхирургия и онкология. 2012 ; (3) : 19–25. https://doi.org/10.17650/2220-3478-2012-0-3-321-338.
23. Алексей А. Трякин, Гульноз Г. Хакимова, Татьяна Н. Заботина, Анна А. Борунова, & Ольга А. Малихова. Современные иммунологические биомаркеры рака толстой кишки. Злокачественные опухоли. 2018 ; 8 : 4 : 50–58. doi: 10.18027/2224-5057-2018-8-4-50-58.
24. De’ Angelis GL, Bottarelli L, Azzoni C, De’ Angelis N, Leandro G, Di Mario F, et al. Microsatellite instability in colorectal cancer. Acta Biomed. 2018 ; 89 (9-S) : 97–101.
25. Suvà ML, Riggi N, Bernstein BE. Epigenetic Reprogramming in Cancer. Science (2013) 339 : 1567–70.
26. Куликов Е.П., Судаков А.И., Никифоров А.А., Мерцалов С.А., Григоренко В.А. Значение полиморфизма генов в развитии колоректального рака. Российский медико-биологический вестник им. академика И.П. Павлова. 2020 : 28 : 2 : 127–134.
Review
For citations:
Seferov B.D., Grickevich O.Yu., Lazarev A.E., Golubinskaya E.P., Maksimova P.E. Molecular genetic characteristics of colorectal cancer. Malignant tumours. 2023;13(4):78-83. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-4-78-83
Views:
637
Email this article 